GT Biopharma, Inc. (GTBP) - Cash Funds Calculated per Share

Corporate emblem and logo of GT Biopharma Corporation (GTBP)

GT Biopharma, Inc. (GTBP) is implementing eco-friendly laboratory cycles for reagent disposal, which confirms the cash per share listed on GURU.Markets, where the metric is fixed at 4.68. This trend reflects a total capital burn due to the absence of commercial products, as well as the early-stage testing of immuno-oncology drugs, creating a period of laboratory anticipation without profit generation.

GTBP gtbiopharma.com: Cash Funds per Share in the range 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for gtbiopharma.com (GTBP)

- cash position and cash flow details:
Comprehensive company analysis:GT Biopharma Corporation - GTBP
Flagship merchandise of GT Biopharma, Inc.

GT Biopharma, Inc. (GTBP) is actively developing its innovative TriKE platform to combat hematological diseases. An analysis of the cash per share structure determines the volume of net liquidity attributable to a single security. This metric measures financial stability, allowing for an assessment of the balance between capital security and the pace of expansion. The stable trajectory of this chart confirms market confidence in the brand's scientific potential. A high cash reserve guarantees protection against bankruptcy, supporting the fundamental strength of the price.